Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.51 |
| ▸ | CYP19A1 | P11511 | 4/20 | 0.49 |
| ▸ | FPR2 | P25090 | 5/20 | 0.48 |
| ▸ | PROKR1 | Q8TCW9 | 5/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | PTGES | O14684 | 1/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 3/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | SCD | O00767 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3979711 | 0.85 | SCD (0.51) | ALDH1A1SMN1; SMN2CYP19A1FPR2PROKR1 | |
| SCHEMBL27265100 | 0.83 | HSD17B10 (0.53) | ALDH1A1SMN1; SMN2CYP19A1KMT2AMEN1 | |
| SCHEMBL5865157 | 0.82 | SCD (0.48) | ALDH1A1SMN1; SMN2CYP19A1KMT2AMEN1 | |
| SCHEMBL5864804 | 0.82 | SCN8A (0.50) | ALDH1A1SMN1; SMN2CYP19A1KMT2AMEN1 | |
| SCHEMBL6815887 | 0.81 | SCD (0.47) | ALDH1A1SMN1; SMN2KMT2ACYP1A2CYP3A4 | |
| SCHEMBL15889780 | 0.81 | ALDH1A1 (0.54) | ALDH1A1SMN1; SMN2CYP19A1FPR2PROKR1 | |
| SCHEMBL5864915 | 0.81 | ALDH1A1 (0.49) | ALDH1A1KMT2AMEN1MAPTLMNA | |
| SCHEMBL22069750 | 0.81 | CYP19A1 (0.55) | ALDH1A1SMN1; SMN2CYP19A1KMT2AMEN1 | |
| SCHEMBL30296552 | 0.81 | CYP19A1 (0.52) | ALDH1A1SMN1; SMN2CYP19A1KMT2AMEN1 | |
| SCHEMBL5864874 | 0.80 | FPR2 (0.52) | ALDH1A1SMN1; SMN2FPR2PROKR1CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7030138-B2 | Benzamidine derivatives | SANKYO COMPANY, LIMITED (JP) | 2006-04-18 | — | — | US | disclosed |
| US-20040147555-A1 | Benzamidine derivatives | SANKYO COMPANY, LIMITED (JP) | 2004-07-29 | — | — | US | disclosed |
| EP-1375482-A1 | BENZAMIDINE DERIVATIVE | Sankyo Company, Limited (JP) | 2004-01-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040147555-A1 | Benzamidine derivatives | F9, F7, F2 | ALDH1A1 1382/4885SMN1; SMN2 4174/4885CYP19A1 1216/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.